Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz

Bodour Salhia and Danielle Goldberg: Rethinking Cancer Research with Illumina's 5-Base Solution

Reinventing PCR: Pranav Patel, N6 Tec

Making Whole Genome Sequencing the Universal Genetic Test - with David Ledbetter, Pediatric Rare Disease Institute, FSU

Remembering Atul Butte with Marina Sirota, Chirag Patel and Mike Snyder

The Age of Digital Pathology with Andy Beck, PathAI

What’s New for Regulatory Informatics in the Age of AI? Not Much—And That’s the Point with Raju Rayavarapu of DNAnexus

From Illumina to Advocacy: Mike Kreitzinger on the Future of Clinical Genomics

Amplifying the Expert: Jing Gao on Illumina's Connected Insights

The End of Animal Testing? Vivodyne Scales Human Tissue with CEO Andrei Georgescu

How Liquid Biopsy Is Becoming Standard of Care with Rita Shaknovich, CMO, Agilent

Tracking GMOs in the Gene Editing Era: Frédéric Debode on the Science of GMO Detection

From Discovery to Translation: Bruker's Bold New Play in Spatial with Joe Beechem and Oliver Braubach

Tagomics Wins NHS Grant, Unveils De-Methylation Platform for Early Cancer Testing with Rob Neely, CSO

From Paris to the Pentagon: Sophie Peresson Maps Biosecurity’s New Landscape

From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision

The Grammar of RNA: Gavin Knott on Gene Editing and Structural Biology in the Age of AI

The Third Way: Christian Schafmeister’s Spiroligomer Revolution

Can Math and AI Replace Some Biology in Drug Discovery? with Aridni Shah, Immunito AI

$10 Genome, $8 Coffee: Rethinking the Economics of Life Science Tools with Stephane Budel, DeciBio